Does High‐Dose Prophylactic Acyclovir Add Benefit in Allogeneic Marrow Transplant Recipients Receiving Prophylactic or Preemptive Ganciclovir?
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details